Biosensors for small‐molecular‐weight metabolites are finding increasing use in medicine for rapid, reagentless point‐of‐care measurement and continuous in vivo monitoring. Though glucose is the most well‐established clinical biosensor application, others include urea and creatinine for assessing renal function; lactic acid for monitoring tissue oxygenation; uric acid for assessing nucleic acid metabolism; cholesterol, triglyceride, and ketones for monitoring lipid metabolism; and bilirubin for liver and blood disorders. Many metabolite biosensors are enzyme electrodes, based on immobilized oxidases, hydrolases, or other enzymes, with amperometric or potentiometric electrochemical reaction monitoring, but other bioreceptors such as computer‐designed proteins and other reaction detection methods such as fluorescence are in use.